Kimura Y, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, Matsui H, et al. Epidemiology of patients with lymphangioleiomyomatosis: a descriptive study using the national database of health insurance claims and specific health checkups of Japan. Respir Investig. 2024;62(3):494–502.

Article  PubMed  Google Scholar 

McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133(2):507–16.

Article  PubMed  CAS  Google Scholar 

Taveira-DaSilva AM, Moss J. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol. 2015;7:249–57.

Article  PubMed  PubMed Central  Google Scholar 

Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, et al. lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness. PLoS ONE. 2015;10(7):e0132546.

Article  PubMed  PubMed Central  Google Scholar 

Yang L, Xiao Y, Ren S. Identification of common genetic features and pathways involved in pulmonary lymphangioleiomyomatosis and ER-positive breast cancer. Medicine (Baltimore). 2023;102(39):e34810.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nunez O, Roman A, Johnson SR, Inoue Y, Hirose M, Casanova A, et al. Study of breast cancer incidence in patients of lymphangioleiomyomatosis. Breast Cancer Res Treat. 2016;156(1):195–201.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nuñez O, Baldi BG, Radzikowska E, Carvalho CRR, Herranz C, Sobiecka M, et al. Risk of breast cancer in patients with lymphangioleiomyomatosis. Cancer Epidemiol. 2019;61:154–6.

Article  PubMed  Google Scholar 

Kelly E, Mhurchu EN, Sukor S, McDonnell TJ, Tryfonopoulos D, Keane MP. Chemotherapy-associated recurrent pneumothoraces in lymphangioleiomyomatosis. Respir Care. 2010;55(11):1491–4.

PubMed  Google Scholar 

Mallory ML, Mitchell MP. Lymphangioleiomyomatosis: a new relative contraindication for breast conservation therapy. Adv Radiat Oncol. 2018;3(1):16–8.

Article  PubMed  Google Scholar 

Franciosi AN, Gupta N, Murphy DJ, Wikenheiser-Brokamp KA, McCarthy C. Diffuse cystic lung disease: a clinical guide to recognition and management. Chest. 2025;167(2):529–47.

Article  PubMed  CAS  Google Scholar 

Yadala V, Jafri H, Legenza MT, Tirona M. Breast cancer in a patient with Birt-Hogg-Dubé syndrome (BHDS) with dramatic response to neoadjuvant chemotherapy. BMJ Case Rep. 2020. https://doi.org/10.1136/bcr-2019-232226.

Article  PubMed  PubMed Central  Google Scholar 

Goodman CD, Nijman SFM, Senan S, Nossent EJ, Ryerson CJ, Dhaliwal I, et al. A primer on interstitial lung disease and thoracic radiation. J Thorac Oncol. 2020;15(6):902–13.

Article  PubMed  Google Scholar 

Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, et al. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur J Cancer (Oxford, England: 1990). 2005;41(11):1628–36.

Article  CAS  Google Scholar 

Tai J, Liu S, Yan X, Huang L, Pan Y, Huang H, et al. Novel developments in the study of estrogen in the pathogenesis and therapeutic intervention of lymphangioleiomyomatosis. Orphanet J Rare Dis. 2024;19(1):236.

Article  PubMed  PubMed Central  Google Scholar 

Lu C, Lee HS, Pappas GP, Dilling DF, Burger CD, Shifren A, et al. A phase II clinical trial of an aromatase inhibitor for postmenopausal women with lymphangioleiomyomatosis. Ann Am Thorac Soc. 2017;14(6):919–28.

Article  PubMed  Google Scholar 

McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, et al. Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016;194(6):748–61.

Article  PubMed  PubMed Central  Google Scholar